Hemodynamical parameters in functional system "motherplacenta-fetus" in women had higher levels of alpha-fetoprotein (AFP) and horionic gonadotropin (HG) in 11 trimester of pregnancy

Abstract

Haemodinamic parameters in the functional system mother-placenta-fetus in 49 women with elevated mildtrimester maternal serum AFP (>2MoM) and in 38 women with elevated maternal serum hCG (>2MoM) were studed. The control group included 32 women with normal mildtnmester serum AFP and hCG. Indexes of impedance to flow in the uterine arteries were significantly higher in patients with elevated MSAFP or MShCG comparing with women of the control group, beginning from 28 weeks of pregnancy. There was a significant association between the maternal serum AFP levels and indexes of impedance to flow in the uterine artery, umbilical artery and fetal aorta during pregnancy. In patients with abnormal (more then 95^th centile) uterine arteries Resistance Index at 2024 weeks, abnormal dynamic of MSAFP and MShCC levels from 16 until 24 weeks was observed. We suppose that unexplained elevated mildtri mester maternal serum AFP and hCC сaп be associated with disturbed utero-placental circulation.

Keywords

Hemodynamic parameters in the functional system "mother-placenta-fetus" in women / alpha-fetoprotein (AFP) level / choriogonic gonadotropin (hCG) / II trimester of pregnancy / the content of AFP and hCG in the blood serum of pregnant women

References

[1] Анастасьева В. Г. Синдром задержки внутриутробного развития плода: Руководство для врачей и студентов медицинских ВУЗов. — Новосибирск, 1996. — С. 4-20.

[2] Кэмпбелл С. Маточный кровоток во время беременности. Материалы I Российского Семинара Международного Общества ультразвуковой диагностики в Акушерстве и Гинекологии. — С.-Петербург, 1998. — С. 35-37.

[3] Медведев М. В. Допплерография в акушерстве. — РАВУЗДПГ, Реальное время».— 1999. — С. 20-44.

[4] Медицинская лабораторная диагностика (программы и алгоритмы). Справочник / Под ред. Карпищенко А. И. — С.-Петербург, Интермедика. — 1997. — С. 180-192.

[5] Beekhuis J. Р. Maternal serum screening for fetal Down’s syndrome and neural tube defects. - London, New-York, 1993. - P. 25-67.

[6] Blot P. Aujard Y. Retard de croissance in utero. Diagnostic, etiologle, surveillance, decesions obstetricales //Arch. Pediatr. - 1996. — N 3. - Suppl. 1. - P. 186s-188s.

[7] Brazerol W. F., Grover S., Donnenfeld A. E. Unexplaned elevated maternal serum a-fetoprotein levels and perinatal outcome in an urban clinic population // Am. J. Obstet. Gynecol. — 1994. —Vol. 171. - P. 030-5.

[8] Carrera J. M., Devesa R., Salvator J. Etiology and pathogenesis of intrauterine growth retardation. In: Textbook of perinatal medicine. — London, New York, The Partenon Publishing Group. — 1998. - Vol. 2. - P. 1180-87.

[9] Cho S., Durfee К. K., Keel B. A. et al. Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFPscreening //J. Perinat. Med. - 1997. - Vol. 25. - P. 476-83.

[10] Jaffa A. J., Yaron Y., Наг-Tool J. at al. Doppler velocimetry of the umbilical artery as a predictor of pregnancy outcome in pregnancies characterized by elevated maternal serum alpha-fetoprotein and normal amniotic fluid alpha-fetoprotein // Fetal. Diagn. Then — 1997. — Vol. 12 (2). - P. 85-8.

[11] Morssink L. P. Biochemical assessment of preghnancy performance in the second trimester // Europ. J. Obstet. Gynecol. Reprod. Biol. — 1999. — Vol. 84. - P. 1-3.

[12] Nicolaides К. H. Placental and fetal Doppler. — The Parthenon Publishing Group. — P. 92-100.

[13] Peeters L. L. The effect of early maternal maladaptation on fetal growth//J. Perinat. Med. — 1994. — Vol. 22. - Suppl. 1. - P. 9-14.

[14] Spong C. Y., Ghidini A., Walker C. N., et al. Elevated maternal serum mirtrimester alphafetoprotein levels are associated with fetoplacental ischemia //Am. J. Obstet. Gynecol. — 1997. — Vol. 177 (5). - P. 1085-7.

[15] Steel S. A., Pearce J. M., Parland P., Chamberlain G. V. P. Early Doppler ultrasound screening in predicting of hypertensive disorders of pregnancy // Lancet. — 1990. - Vol. 335. - P. 1548-51.

[16] Wald N. J., Kennard A. Prenatal screening for neural tube defects and Down syndrome. In Principles and Practice of Medical Genetics. - Ed. by Rimon D. L., Connor J. M., Pyeritz R. E. - Ch. Livingstone. —1997 - Vol. I. - P. 545-61.

[17] Wenstrom K. D., Owen J., Boots L. R. et al. Elevated second- trimester human chorionic gonadotropin levels in association with poor pregnancy outcome //Am. J. Obstet. Gynecol. — 1994. —Vol. 171. - P. 1038-41.

[18] Yaron Y., Jaffa A. J., Наг-Tool J. at al. Doppler velocimetry of the umbilical artery as a predictor of outcome in pregnancies characterized by elevated betasubunit human chorionic gonadotropin // Fetal. Diagn. Ther. —1997 12. - P. 353-55.

RIGHTS & PERMISSIONS

Eсо-Vector